ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,107,592 | -8.6% | 43,350 | +2.6% | 0.00% | – |
| Q2 2023 | $1,211,788 | +15.3% | 42,252 | -3.7% | 0.00% | – |
| Q1 2023 | $1,051,324 | +41.0% | 43,860 | -0.3% | 0.00% | – |
| Q4 2022 | $745,816 | +13.9% | 43,975 | -0.6% | 0.00% | – |
| Q3 2022 | $655,000 | -26.2% | 44,224 | -21.5% | 0.00% | – |
| Q2 2022 | $887,000 | -41.5% | 56,348 | +0.1% | 0.00% | – |
| Q1 2022 | $1,517,000 | -19.3% | 56,273 | +10.8% | 0.00% | – |
| Q4 2021 | $1,879,000 | – | 50,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |